X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6) 6
humans (5) 5
animals (3) 3
cancer (3) 3
cell line, tumor (3) 3
head and neck neoplasms - pathology (3) 3
mice (3) 3
mice, scid (3) 3
oncology (3) 3
adult (2) 2
aged (2) 2
aged, 80 and over (2) 2
basal cell carcinoma (2) 2
biphenyl compounds - administration & dosage (2) 2
biphenyl compounds - adverse effects (2) 2
carcinoma, basal cell - drug therapy (2) 2
carcinoma, squamous cell - pathology (2) 2
care and treatment (2) 2
chemotherapy (2) 2
double-blind method (2) 2
female (2) 2
growth (2) 2
head and neck neoplasms - genetics (2) 2
in-vivo (2) 2
inhibition (2) 2
male (2) 2
metastasis (2) 2
middle aged (2) 2
open-label (2) 2
pyridines - administration & dosage (2) 2
pyridines - adverse effects (2) 2
resistance (2) 2
skin (2) 2
skin neoplasms - drug therapy (2) 2
skin neoplasms - pathology (2) 2
squamous cell carcinoma (2) 2
vismodegib (2) 2
610 medicine & health (1) 1
ac133 antigen (1) 1
acute myeloid-leukemia (1) 1
adenocarcinoma cellular invasiveness (1) 1
adjuvant treatment (1) 1
advanced basal cell carcinoma (1) 1
analysis (1) 1
antigens, cd - analysis (1) 1
antigens, cd - genetics (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
apoptosis (1) 1
apoptosis - genetics (1) 1
basal cell carcinoma outcomes with lde225 treatment study (1) 1
biochemistry & molecular biology (1) 1
biphenyl compounds (1) 1
biphenyl compounds - therapeutic use (1) 1
braf (1) 1
breast-cancer (1) 1
cancer research (1) 1
cancer stem-cells (1) 1
carcinoembryonic antigen cea (1) 1
carcinoma, basal cell (1) 1
carcinoma, basal cell - pathology (1) 1
carcinoma, basal cell - radiotherapy (1) 1
carcinoma, basal cell - secondary (1) 1
carcinoma, basal cell - surgery (1) 1
carcinoma, squamous cell - etiology (1) 1
carcinoma, squamous cell - genetics (1) 1
ceacam6 (1) 1
cell adhesion & migration (1) 1
cell adhesion molecules (1) 1
cell adhesion molecules - analysis (1) 1
cell adhesion molecules - genetics (1) 1
cell culture (1) 1
cell death - drug effects (1) 1
cell proliferation (1) 1
cell survival - drug effects (1) 1
cell transformation, neoplastic - genetics (1) 1
cells (1) 1
chemoradiation (1) 1
cisplatin - pharmacology (1) 1
cisplatin - therapeutic use (1) 1
cleaved caspase 3 (1) 1
clinical trials (1) 1
clone cells (1) 1
cloning (1) 1
colleges & universities (1) 1
corn (1) 1
dermatology (1) 1
dermatology clinic (1) 1
determinant (1) 1
disease progression (1) 1
disease-free survival (1) 1
dna (1) 1
dose-escalation (1) 1
drug dosages (1) 1
drug therapy (1) 1
efficacy (1) 1
european-organization (1) 1
evolution (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 716 - 728
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 113 - 125.e5
Background The hedgehog pathway inhibitor sonidegib demonstrated meaningful tumor shrinkage in more than 90% of patients with locally advanced basal cell... 
Dermatology | Basal Cell Carcinoma Outcomes with LDE225 Treatment study | hedgehog pathway inhibitor | sonidegib | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | advanced basal cell carcinoma | Locally advanced basal cell carcinoma | Advanced basal cell carcinoma | Metastatic basal cell carcinoma | Sonidegib | Hedgehog pathway inhibitor | HEDGEHOG PATHWAY | MULTICENTER | VISMODEGIB | MANAGEMENT | EFFICACY | GUIDELINES | OPEN-LABEL | DERMATOLOGY | DOSE-ESCALATION | UPDATE | INHIBITOR | Skin Neoplasms - drug therapy | Humans | Middle Aged | Carcinoma, Basal Cell - secondary | Biphenyl Compounds - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Biphenyl Compounds - therapeutic use | Young Adult | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Smoothened Receptor - antagonists & inhibitors | Pyridines - therapeutic use | Skin Neoplasms - pathology | Pyridines - administration & dosage | Double-Blind Method | Survival Rate | Disease Progression | Biphenyl Compounds - administration & dosage | Carcinoma, Basal Cell - drug therapy | Aged | Medical research | Care and treatment | Basal cell carcinoma | Analysis | Patient outcomes | Corn | Medicine, Experimental | Skin | Metastasis | Drug therapy | Cancer
Journal Article
Molecular Cancer, ISSN 1476-4598, 09/2012, Volume 11, Issue 1, pp. 74 - 74
Background: Overexpression of CEACAM6 has been reported for a number of malignancies. However, the mechanism of how CEACAM6 contributes to cancer formation and... 
Cleaved Caspase 3 | CEACAM6 | Tumour initiation | HNSCC | CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR | DETERMINANT | CARCINOEMBRYONIC ANTIGEN CEA | ADENOCARCINOMA CELLULAR INVASIVENESS | HETEROGENEITY | INHIBITION | EVOLUTION | ONCOLOGY | RESISTANCE | EXPRESSION | Cell Adhesion Molecules - genetics | Cell Proliferation | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Imidazoles - administration & dosage | Apoptosis - genetics | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Quinolines - administration & dosage | Antigens, CD - genetics | Quinolines - pharmacology | Gene Knockdown Techniques | Squamous Cell Carcinoma of Head and Neck | Cell Transformation, Neoplastic - genetics | Proto-Oncogene Proteins c-akt - metabolism | Gene Expression | Imidazoles - pharmacology | Mice, SCID | Head and Neck Neoplasms - pathology | Animals | Cell Line, Tumor | Head and Neck Neoplasms - genetics | Mice, Inbred NOD | Mice | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | GPI-Linked Proteins - genetics | Head and neck cancer | Chemotherapy | Squamous cell carcinoma | Cancer | Apoptosis | Cell adhesion molecules | Proteins | Cell culture | Pancreatic cancer | Cloning | Colleges & universities | Manufacturers | Head & neck cancer | Experiments | Manuscripts | Cell adhesion & migration
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2019, Volume 123, pp. 155 - 161
The aim of the study was to assess the impact of treatment with adjuvant vemurafenib monotherapy on health-related quality of life (HRQOL) in patients with... 
Resected melanoma | Health-related quality of life | Vemurafenib | BRAF | Adjuvant treatment
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.